SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…
The Rise of Integrated Financial Platforms
One of the most celebrated sales pitches of all time occurred when then-Apple (AAPL) CEO Steve Jobs first…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q3 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
Powering the Future of Efficient AI Computing
Arm Holdings plc ARM has emerged as a cornerstone of artificial intelligence innovation, driving efficiency and scalability across…
Can Quantum Computing’s Government Contracts Boost Future Growth?
Quantum Computing Inc. or “QCi” QUBT is continuously focused on strengthening its engagement with strategic government partners. During…
Can FUTU’s Wealth Management Take Off?
Futu Holdings Limited FUTU reported a record year-over-year client asset surge of 68.1% and a sequential 17.4% rise…
Quantum Computing Expands Global Reach With New Research Collabs
Quantum Computing Inc. QUBT or QCi continues to gain traction among key academic and research partners worldwide. Recently,…
Dropbox, Crexendo Remain Our Top Picks in Internet Services
Macro factors currently driving the economy, such as inflation, interest rates, labor markets, supply chain issues and so…
Which Quantum Computing Stock Is the Smarter Buy?
Quantum computing is moving from lab prototypes to commercial pathways, and for investors, two pure-play names, Rigetti Computing…
Can Rigetti Computing’s Margin Recover After Second-Quarter Pressure?
Rigetti Computing’s RGTI second-quarter 2025 results gave investors a closer look at the pressures weighing on margins as…